Biogen, Inc. (BIIB)

191.77 -0.31 (-0.16%) USD  |  NASDAQ  |  Feb 20, 14:18
More

Biogen Tobin's Q (Approximate) (Quarterly)

Tobin's Q (Approximate) (Quarterly) Chart

View Tobin's Q (Approximate) (Quarterly) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Tobin's Q (Approximate) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years

View Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Tobin's Q (Approximate) (Quarterly) Benchmarks

View Tobin's Q (Approximate) (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade